Skip to main content

Advertisement

SpringerLink
Log in

NANOMEDICINE

Protected rituximab aims at brain metastases

  • News & Views
  • Published:

From Nature Biomedical Engineering

View current issue Submit your manuscript

Encapsulation of the therapeutic monoclonal antibody rituximab, and its molecular targeting to brain metastases of B-cell lymphoma, significantly boosts the antibody’s therapeutic effectiveness in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Encapsulation and functionalization of a therapeutic antibody against lymphomas.

References

  1. Wong, H. L., Wu, X. Y. & Bendayan, R. Adv. Drug Deliv. Rev. 64, 686–700 (2012).

    Article  CAS  Google Scholar 

  2. Banks, W. A. Nat. Rev. Drug Discov. 15, 275–292 (2016).

    Article  CAS  Google Scholar 

  3. Aragon-Ching, J. B., Williams, K. M. & Gulley, J. L. Front. Biosci. 12, 4957–4971 (2007).

    Article  CAS  Google Scholar 

  4. Bendayan, R., Lee, G. & Bendayan, M. Microsc. Res. Tech. 57, 365–380 (2002).

    Article  CAS  Google Scholar 

  5. Rubenstein, J. L. et al. Blood 101, 466–468 (2003).

    Article  CAS  Google Scholar 

  6. Gan, H. K., Azad, A., Cher, L. & Mitchell, P. L. Neuro. Oncol. 12, 212–215 (2010).

    Article  Google Scholar 

  7. Rezvani, A. R. & Maloney, D. G. Best. Pract. Res. Clin. Haematol. 24, 203–216 (2011).

    Article  CAS  Google Scholar 

  8. Abès, R., Gélizé, E., Fridman, W. H. & Teillaud, J. L. Blood 116, 926–934 (2010).

    Article  Google Scholar 

  9. Rubenstein, J. L., Gupta, N. K., Mannis, G. N., Lamarre, A. K. & Treseler, P. Blood 122, 2318–2330 (2013).

    Article  CAS  Google Scholar 

  10. Wen, J. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0434-z (2019).

    Article  CAS  Google Scholar 

  11. Hussain, S. K. et al. Cancer Epidemiol. Biomark. Prev. 22, 295–307 (2013).

    Article  CAS  Google Scholar 

  12. Melkus, M. W. et al. Nat. Med. 12, 1316–1322 (2006).

    Article  CAS  Google Scholar 

  13. Shi, N., Zhang, Y., Zhu, C., Boado, R. J. & Pardridge, W. M. Proc. Natl Acad. Sci. USA 98, 12754–12759 (2001).

  14. He, C. et al. Adv. Funct. Mater. 28, 1705668 (2018).

    Article  Google Scholar 

  15. Wu, D. et al. Adv. Mater. 31, e1807557 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada

    Reina Bendayan

Authors
  1. Reina Bendayan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reina Bendayan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bendayan, R. Protected rituximab aims at brain metastases. Nat Biomed Eng 3, 678–679 (2019). https://doi.org/10.1038/s41551-019-0451-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-019-0451-y

  • Springer Nature Limited

Search

Navigation